They have presented at two Conferences recently. This brought in new investor interest. It is up to them to hold that interest. They mentioned they were going to the FDA about late stage trials. I would have liked more details. My guess is we won't hear until Jan about Indaflex but, will get some smaller positive updates on other products.
0 members recommend this.
